C12N2770/36111 - CPC Classification Index

ClassID:

111669 ⎘

C12N2770/36111 - CPC Classification

Classification description:

ssRNA viruses positive-sense; Details; Togaviridae Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki

Sub-classes:

C12N2770/36121 » Viruses as such, e.g. new isolates, mutants or their genomic sequences 41
C12N2770/36122 » New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes 129
C12N2770/36123 » Virus like particles [VLP] 58
C12N2770/36131 » Uses of virus other than therapeutic or vaccine, e.g. disinfectant 5
C12N2770/36132 » Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent 24
C12N2770/36133 » Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory 3
C12N2770/36134 » Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein 185
C12N2770/36141 » Use of virus, viral particle or viral elements as a vector 4
C12N2770/36151 » Methods of production or purification of viral material 38
C12N2770/36161 » Methods of inactivation or attenuation 18
C12N2770/36171 » Demonstrated in vivo effect 38
C12N2770/36188 » For redistribution 0

Recent Application in this class:

20240209379

2024-06-27

COMPOSITIONS AND METHODS FOR ENHANCING GENE EXPRESSION

20210389324

2021-12-16

Methods and Compositions for the Detection of Host Protein Cleavage by Group IV Viral Proteases

20210347863

2021-11-11

Nucleic acids encoding single domain antibodies to chikungunya virus

20200399349

2020-12-24

Broad-spectrum monoclonal antibodies against chikungunya virus E1 structural protein

20200024331

2020-01-23

Single domain antibodies to Chikungunya virus

20190293649

2019-09-26

Proteome Editing System

20190085058

2019-03-21

DNA antibody constructs and method of using same

20180171340

2018-06-21

Compositions and methods for enhancing gene expression

20180149651

2018-05-31

Proteome Editing System and A Biomarker of Veev Infection

#10

20180134778

2018-05-17

Methods and compositions for treating an alphavirus infection

#11

20160311891

2016-10-27

DNA antibody constructs and method of using same

#12

20140079734

2014-03-20

Methods and compositions for alphavirus replicons

#13

20140065178

2014-03-06

Methods and compositions for pseudoinfectious alphaviruses

#14

20120220033

2012-08-30

INHIBITION OF VIRAL GENE EXPRESSION USING SMALL INTERFERING RNA

#15

20110269816

2011-11-03

Inhibition of viral gene expression using small interfering RNA

#16

20110158982

2011-06-30

COMPOSITIONS AND METHODS FOR INHIBITING MAdCAM

#17

20090170794

2009-07-02

Small interfering rnas that efficiently inhibit viral expression and methods of use thereof

#18

20090035255

2009-02-05

Fusion protein of antibody L19 against fibronectin ED-B and interleukin 12

#19

20080241881

2008-10-02

Modified clostridial toxins with enhanced translocation capabilities and altered targeting activity for clostridial toxin target cells

#20

20070149470

2007-06-28

Inhibition of viral gene expression using small interfering RNA

#21

20070142275

2007-06-21

Peptides with the capacity to bind to transforming growth factor β1 (TGF-β1)